What insurance covers Zepbound and Wegovy?

Your employer usually decided this, not your insurer. Here is how to get a definitive answer about your own plan, payer by payer, rather than a general one.
✓  More than 10,000 patients
✓  No insurance required
✓  100% Online
✓  Free and discreet delivery
✓  Licensed US practitioners
Medically reviewed by a licensed US practitioner. Last updated September 2026.
The honest answer to "does my insurance cover Zepbound®" is that your insurer is usually not the one who decided. For most people with employer coverage, the insurance company administers a benefit the employer bought. Two people can both hold Aetna cards, work for different companies, and get different answers about the same drug.

That is why every article you have read says it depends. Below is what each major payer has typically done, the named-plan questions one by one, the sleep apnea question, the phone script that gets you a real answer, and what to do if the answer is no.
Nothing on this page is a coverage determination. Only your plan can confirm what your plan covers. Everything here is a starting point for that conversation, and every payer section below tells you how to check rather than telling you what your answer will be.

Coverage at a glance, by payer.

Every row describes what was typical as of September 2026, not what is certain, and any row can be overridden by your own plan document. Treat the table as a map of where to look. Each row has a matching section below telling you how to check your own.
Payer
Aetna (CVS Health)
UnitedHealthcare (OptumRx)
Cigna (Express Scripts)
Blue Cross Blue Shield
Kaiser Permanente
Medicare Part D
Medicaid
TRICARE
VA
FEHB (federal employees)
Marketplace (ACA) plans
Typical position as of September 2026
Coverage common on plans with a weight management rider. Standard template formularies have designated a preferred GLP-1 and excluded the other
Depends on whether the employer purchased weight management benefits
Available on plans that elect it, often through a managed weight management program
Varies by licensee. Some cover, some have withdrawn coverage for certain groups
Regional formularies, generally restrictive for weight management
Cannot cover for weight loss alone. May cover for another medically accepted indication
Varies by state. A minority of states cover anti-obesity medication
Covered through the pharmacy benefit subject to criteria
Available subject to criteria for use
Carriers have been directed to cover at least one anti-obesity medication
Varies by plan and state. Frequently excluded
Prior authorization
Yes
Yes
Yes
Yes
Yes
Yes, where covered
Yes, where covered
Yes
Yes
Yes
Yes, where covered
Where to check
Your Aetna member portal drug list for the current plan year
Your prescription drug list in your member account
Member services, asking whether program enrolment is a condition
The formulary of the licensee named on your card
Your Kaiser pharmacy or member services, for your region's current criteria
Your plan's formulary and Medicare.gov
Your state Medicaid preferred drug list
The criteria published by the Defense Health Agency
VA formulary criteria, through your VA provider
Your carrier's brochure and formulary, since which one varies
The plan's formulary, before you enrol rather than after
Preferred product choices shift, and they shift on a calendar. Pharmacy benefit managers periodically designate one GLP-1 as preferred and drop another, and tier placement is commonly reviewed with changes effective 1 January. A drug covered in January can be excluded in July. Check the formulary for the plan year you are actually in.

Payer by payer, and how to check yours.

Does Aetna cover Zepbound?
‍

Some Aetna plans do and some do not, and the deciding factor is usually your employer's benefit design rather than Aetna itself.

Aetna is part of CVS Health, and many Aetna plans use CVS Caremark as the pharmacy benefit manager. Caremark publishes standard template formularies that employers can adopt as-is or customize, and in cycles through September 2026 those templates have designated a preferred GLP-1 for weight management and excluded the alternative, which has affected Zepbound on some standard templates. Preferred-product decisions are revisited, so the template in force for your plan year is the one that matters.

How to check. Log in to your Aetna member portal, find the drug list attached to your plan, and search Zepbound by name. If a preferred alternative appears instead, ask your prescriber about a formulary exception request. If your employer customized the formulary, none of the template logic necessarily applies to you. Either way, expect prior authorization with documented BMI criteria and often a documented comorbidity. Only your plan can confirm your coverage.

Does UnitedHealthcare cover Zepbound?
‍

Sometimes, and again it usually comes down to whether your employer bought weight management coverage.

UnitedHealthcare commercial plans typically use OptumRx as the pharmacy benefit manager. Where an employer purchased weight management benefits, Zepbound has generally been available with prior authorization through September 2026. Where the employer declined that rider, the medication is excluded regardless of medical necessity, and appealing a benefit exclusion is harder than appealing a failed authorization.

How to check. Open your plan's prescription drug list in your member account and search Zepbound. A prior authorization flag means covered with conditions. If it is excluded or absent, ask member services specifically whether your plan includes a weight management pharmacy benefit. Tier placement is reviewed annually with changes commonly effective 1 January, so a plan that covered it last year is worth rechecking each January. Only your plan can confirm this.

Does Cigna cover Zepbound or Wegovy?
‍

Cigna plans typically use Express Scripts as the pharmacy benefit manager. As of September 2026, coverage was generally available to employers that elect it, frequently as part of a managed program that may require enrolment in a weight management service alongside the prescription.

How to check. Ask member services which program, if any, applies to you, and ask specifically whether program enrolment is a condition of coverage. That requirement is easy to miss and it will hold up an otherwise approvable prior authorization. Ask for the written criteria before your prescriber submits.

Does Blue Cross Blue Shield cover Zepbound?
‍

There is no single answer, because Blue Cross Blue Shield is not a single company. More than 30 independent licensees operate under the brand, each with its own formulary, criteria and coverage policy. As of September 2026, some covered anti-obesity medication broadly and some had withdrawn coverage for particular employer groups.

How to check. Find your licensee, usually named on your card, and look up its formulary directly. A coverage policy from another state's Blue plan tells you nothing about yours, and neither does a general article about the brand. Only the licensee that issued your card can confirm your coverage.

Does Kaiser Permanente cover Zepbound?
‍

Kaiser operates an integrated model with regional formularies, and through September 2026 coverage for weight management medication has generally been restrictive, with criteria applied internally and often requiring documented participation in a structured weight management program first.

How to check. Ask your Kaiser pharmacy or member services for the current criteria in your region, because they are set regionally and revised.

Does Medicare cover Zepbound or Wegovy?
‍

This is the question with the clearest rule and the most confusion around it. Medicare Part D cannot cover a drug used for weight loss alone. That is a statutory exclusion, not an insurer's choice, and it applies to Medicare Advantage prescription drug plans too.

The same drug can be covered for a different medically accepted indication. Wegovy® carries an indication for reducing cardiovascular risk in adults with established cardiovascular disease who also have overweight or obesity, and following CMS guidance Part D plans have been able to cover it for that indication. Zepbound carries an indication for moderate to severe obstructive sleep apnea in adults with obesity, also a medically accepted indication other than weight loss. Ozempic® and Mounjaro® are approved for type 2 diabetes and routinely covered for that use.

How to check. Ask your plan which indication it would evaluate a request under, and confirm the current position on Medicare.gov. Federal policy here has been actively changing, with proposals affecting Medicare and Medicaid coverage of anti-obesity medication announced through September 2026, so anything written more than a few months ago, including this page, should be verified against the plan itself. Note also that manufacturer savings cards are not available to Medicare beneficiaries under federal anti-kickback rules, even when the plan does not cover the drug.

Does Medicaid cover Zepbound or Wegovy?
‍

Medicaid coverage of anti-obesity medication is a state-by-state decision, and as of September 2026 only a minority of states covered it for weight management. Where a state does, prior authorization and specific clinical criteria apply, and coverage for type 2 diabetes medication is far more common than coverage for weight management.

How to check. Look up your state Medicaid agency's preferred drug list directly, since no general statement covers all states. As with Medicare, manufacturer savings cards are not available to Medicaid beneficiaries.

Is Wegovy covered by insurance?
‍

More often than Zepbound on some formularies, less often on others, and the same employer-rider logic governs both. Three things change the odds with Wegovy specifically.

The cardiovascular indication. Wegovy is approved for reducing cardiovascular risk in adults with established cardiovascular disease who also have overweight or obesity. Some plans that exclude weight management medication will cover it under this separate indication. If that describes you, ask your plan explicitly and ask your clinician whether it applies.

Preferred-product status. Where Wegovy holds preferred status on your formulary, coverage is more likely and the authorization path simpler. Ask which product your plan prefers this year, not last year.

Documented comorbidity. As of September 2026, most criteria covered a BMI of 30 or above, or 27 or above with at least one weight-related condition such as hypertension, type 2 diabetes, dyslipidemia or obstructive sleep apnea. Ask your plan for its exact written criteria. A chart that documents the comorbidity is often the difference between approval and denial. Only your plan can confirm whether Wegovy is covered for you.

Will insurance cover Zepbound for sleep apnea?
‍

Sometimes, and it is a genuinely different question from weight management coverage. Zepbound is approved for moderate to severe obstructive sleep apnea in adults with obesity, an approved indication in its own right, which matters in two ways.

For Medicare Part D, it is a medically accepted indication other than weight loss, which places it outside the statutory weight loss exclusion.

For commercial plans, a plan that excludes weight management medication may still evaluate a request under the sleep apnea indication, because the exclusion is written against the use, not the molecule.

How to check. Ask your plan whether it evaluates requests under the obstructive sleep apnea indication separately from weight management, and ask for the written criteria before your prescriber submits. What plans have typically wanted to see, as of September 2026, is a diagnosis of moderate to severe obstructive sleep apnea supported by a sleep study, documented obesity, and often documentation about positive airway pressure therapy, whether you use it, tolerate it, or could not.

Two cautions. This route requires an actual diagnosis established by appropriate testing, which is a clinical matter and not a coverage strategy. And coverage still varies by plan, so only your plan can confirm it. Ask your prescriber whether the indication applies to you before building a plan around it.

How to get a real answer in one phone call.

Call the member services number on your card and ask these, in order. Write down the answers and the call reference number.

1. Does my plan cover weight management medication, or is it excluded?

2. Is Zepbound on my formulary? Is Wegovy? What tier is each one?

3. Is prior authorization required, and what exactly are the criteria?

4. Is there a step therapy requirement? If so, which medication must I try first, and for how long?

5. Is there a quantity limit or an annual or lifetime maximum on this benefit?

6. If it is not covered for weight management, would it be considered under another approved indication?

7. What is my copay if approved, and does it change once I hit my deductible?
Question one does most of the work. If weight management medication is excluded from your benefit, the rest is academic, and you are looking at an exclusion rather than a criteria problem. Those have different fixes.

If your authorization is denied.

Get the denial in writing and read which category it falls into, because the three denials have three different fixes.

A benefit exclusion means the plan does not cover the drug class at all. A formulary exception request supported by clinical documentation is still worth filing, but the odds are lower.

A failed prior authorization means the drug is covered but the documentation did not meet the criteria. This is the most fixable outcome, and the usual gaps are a missing BMI record, an undocumented comorbidity, or no record of prior weight management attempts. Ask your prescriber's office to resubmit with the gap closed.

Step therapy means trying something else first. Ask what, for how long, and whether a documented intolerance satisfies the requirement.

Every denial carries an appeal deadline. Note it, and ask about external review, which gives you an independent reviewer outside the insurer once internal appeals are exhausted. Our guide to getting a GLP-1 without insurance covers what to do while an appeal is pending.

If the answer is no.

Coverage is not the only route to treatment, and for many people it is not the fastest. Society is a cash-pay telehealth practice, so there is no prior authorization, no step therapy, no formulary exclusion and no appeal. A licensed US practitioner reviews your history and prescribes if it is appropriate, usually responding within a day or two of your free 2-minute evaluation.

Plans start at $99 per month for metformin, $149 for semaglutide and $249 for tirzepatide, and run to $1,695 for brand Wegovy, each covering a personalized treatment plan, the medication, labs, expedited shipping and continuous clinical assistance. Those are starting prices, so ask for your own figure before you compare. Society does not offer Zepbound. Full detail is on our pricing page.

Be clear about the trade. You are paying cash, and your plan will not reimburse you, because no claim is filed. And if your plan does cover the medication, using that coverage will almost always cost you less than paying us. We would rather tell you that than have you find out later.
Before you start anywhere, read the refund terms rather than the cancellation terms. Ours: you can pause, switch or cancel anytime and cancelling stops future billing cycles, the first two months of any treatment plan are non-refundable, and refund requests must be submitted within 28 days of the charge. The full terms are in our refund and cancellation policy.

Insurance questions, answered.

Important safety information
GLP-1 based treatments may carry risks, including the potential for thyroid C-cell tumors. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Side effects may include nausea, headaches or dizziness, fatigue or changes in appetite, gastrointestinal discomfort, and injection-site reactions.

Compounded medications are not FDA-approved and have not been evaluated by the Food and Drug Administration for safety, efficacy, or quality.

If cash-pay is the route that fits.

No insurance required, no authorization, no waiting on a decision. The free 2-minute evaluation gives you your own price. You can pause, switch or cancel anytime, which stops future billing cycles, and the first two months of any treatment plan are non-refundable.
Get started
© 2026 Society. All rights reserved.
* Individual results may vary, and not all patients will qualify for treatment. Always consult a licensed healthcare provider before starting or modifying any medical treatment.

Society facilitates access to consultations with independent, licensed healthcare providers who evaluate each patient and determine eligibility for treatment. Prescription products require an online medical evaluation. Medications are prescribed by independent physicians and dispensed by licensed U.S. pharmacies or a patient's preferred pharmacy. Only a qualified healthcare provider can determine whether a treatment is appropriate for an individual's specific medical needs.
Providers are licensed in the state where the patient is located at the time of consultation, and availability may vary by state.
Society's services are intended for individuals 18 years of age or older. Age verification may be required as part of the intake process.
‍Society partners with licensed U.S. pharmacies. Certain treatments may include compounded medications, which are not FDA-approved and have not been evaluated by the Food and Drug Administration for safety, efficacy, or quality. Compounded medications may be prescribed by a healthcare provider based on individual patient needs or during periods of drug shortages. FDA-approved GLP-1 medications—such as Ozempic® (semaglutide), Wegovy® (semaglutide), and Zepbound® (tirzepatide)—are not compounded. Society is not affiliated with, endorsed by, or sponsored by the manufacturers of these products. All trademarks and brand names belong to their respective owners.
GLP-1–based treatments may carry risks, including the potential for thyroid C-cell tumors. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Please consult a healthcare provider for complete prescribing and safety information.
Prescription medications are dispensed only when determined appropriate by a licensed healthcare provider following an online medical evaluation. No prescription is guaranteed, and treatment decisions are made solely at the prescriber's clinical discretion.
Statements on this website have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Images shown are for illustrative purposes only; actual product appearance may vary.